Why Supplement NDA and Intellectual Property Protection Matters for Brands

At SREKE, we understand that launching a supplement brand involves far more than selecting effective ingredients. Protecting your formulation through New Dietary Ingredient (NDI) notifications and intellectual property strategies is essential to maintaining a competitive edge in a market where 84% of U.S. consumers now purchase dietary supplements online or in-store annually, according to the Natural Products Industry Market Report.

Under the Dietary Supplement Health and Education Act (DSHEA) of 1994, any dietary ingredient introduced after October 15, 1994, requires a premarket NDI notification submitted to the FDA at least 75 days before marketing. This regulatory requirement is not optional — it is a legal mandate enforced by the FDA under 21 CFR Part 190. Failure to file an NDI notification can result in your product being classified as an "adulterated" product, exposing your brand to warning letters, import alerts, and market removal.

Beyond regulatory compliance, intellectual property (IP) protection is equally critical. While dietary supplements cannot be patented in the same way pharmaceuticals are, brand owners can protect their formulations through trade secrets, trademarks on product names and branding, and in some cases, process patents. At SREKE, we work closely with our partners to ensure every aspect of IP protection is addressed before production begins.

Key Manufacturing Considerations at SREKE

NDI Notification Support

Our GMP-certified facility in Guangzhou, China, supports brand owners through every stage of the NDI process. We maintain detailed documentation for all raw materials, including chemical identity, purity specifications, and manufacturing process descriptions — all required elements under FDA NDI guidance. Our quality assurance team ensures that every ingredient dossier meets the standards outlined in 21 CFR Part 111, which governs current Good Manufacturing Practices for dietary supplements.

Intellectual Property Safeguards

At SREKE, IP protection is embedded in our manufacturing workflow. We implement the following measures:

• Confidentiality agreements (NDAs) signed before any formulation discussion
• Segregated production lines for proprietary formulations
• Restricted access to formulation data with role-based authentication
• Secure digital document management with audit trails
• Ingredient substitution protocols that protect trade secrets without compromising compliance

Our facility operates under ISO 22000-certified food safety management systems and HACCP protocols, which further reinforce our ability to safeguard proprietary processes. These certifications are independently audited and verify that our quality management systems meet internationally recognized standards.

Formulation and Compliance

We recommend that brand owners engage in formulation development before committing to large production runs. Our R&D team works within FDA GRAS (Generally Recognized as Safe) lists and EFSA (European Food Safety Authority) approved ingredient lists to ensure compliance across target markets. Our compliance team cross-references every formulation against:

• FDA dietary supplement labeling regulations (21 CFR Part 101)
• EFSA Novel Food Catalogue for EU market entry
• Health Canada Natural Health Products Regulations where applicable
• National regulation databases for ASEAN, Middle East, and African markets

MOQ and Lead Time Transparency

At SREKE, we provide clear MOQ and lead time commitments upfront. Our standard MOQ ranges vary by product form:

• Softgels: 10,000–50,000 units per SKU
• Capsules: 10,000–50,000 units per SKU
• Tablets: 20,000–100,000 units per SKU
• Powders: 5–50 kg per SKU
• Gummies: 10,000–50,000 units per SKU
• Liquids: 5,000–30,000 units per SKU

Standard lead times range from 30 to 60 days depending on formulation complexity, packaging customization, and regulatory documentation requirements. Expedited production is available for qualified partners.

How SREKE Helps You Get to Market Faster

Time-to-market is a decisive factor in supplement brand success. At SREKE, we streamline the path from concept to shelf through integrated OEM and ODM services. Our in-house capabilities include formulation development, stability testing, analytical method validation, packaging design, and regulatory consulting — all under one roof.

Integrated NDI Filing Support

Our compliance team prepares NDI notification dossiers that meet FDA structural and content requirements, including:

• Quality information (identity, purity, strength, composition)
• Manufacturing process information
• Non-harmfulness information and exposure data
• Any other information relevant to safety

We maintain a library of previously filed NDI notifications and can reference published safety data from peer-reviewed literature and databases such as the FDA's NDI Compilation and the EFSA Journal to support your filing. This reduces the time and cost associated with de novo safety assessments.

Stability Testing and Shelf-Life Determination

Accelerated and real-time stability testing conducted at our GMP laboratory provides the data required for label expiration dating. We follow ICH Q1A(R2) guidelines for stability testing of new drug substances and products, adapted for dietary supplement requirements. This ensures your product maintains potency and quality throughout its labeled shelf life.

Packaging and Labeling Compliance

Our packaging team designs and produces labels that comply with FDA 21 CFR Part 101 dietary supplement labeling requirements and EU Regulation (EU) No 1169/2011 for European markets. We verify that Supplement Facts panels, ingredient declarations, allergen statements, and structure/function claims meet all regulatory thresholds before production begins.

Industry Trends and Market Opportunities

The global dietary supplement market was valued at approximately USD 186 billion in 2024 and is projected to grow at a CAGR of 7.6% through 2030, according to industry analysis from Grand View Research. This growth is driven by increasing consumer demand for preventive health solutions, personalized nutrition, and clean-label products.

Key Trends Shaping the Industry

• Personalized supplements: The personal vitamins and supplements segment is one of the fastest-growing categories, with consumers seeking formulations tailored to specific health goals.
• Clean-label and organic ingredients: EFSA and FDA scrutiny of synthetic additives has accelerated demand for naturally derived ingredients with transparent sourcing.
• Novel delivery formats: Gummies, effervescent tablets, and liquid shots continue to gain market share, particularly among younger demographics.
• Adaptogens and nootropics: Ingredients such as ashwagandha, lion's mane, and L-theanine have seen significant NDI notification activity and consumer adoption.
• Sustainability: Eco-friendly packaging and sustainably sourced ingredients are becoming purchasing criteria for an increasing share of consumers.

At SREKE, we monitor these trends continuously and advise our partners on formulation opportunities that align with both market demand and regulatory feasibility. Our ODM catalog includes over 200 pre-developed formulas that can be customized, allowing brands to launch with reduced development time and lower NDI risk.

Frequently Asked Questions

What is an NDI notification and when is it required?

An NDI (New Dietary Ingredient) notification is a submission to the FDA required before marketing a dietary supplement containing an ingredient not marketed in the U.S. before October 15, 1994. The notification must be filed at least 75 days before product launch. At SREKE, we assist partners in determining whether their ingredients require NDI filing and prepare the necessary documentation.

Can a supplement formulation be patented?

While the specific combination of ingredients in a supplement may be eligible for a utility patent if it meets novelty and non-obviousness requirements, many brand owners rely on trade secret protection and trademarks. At SREKE, we recommend a hybrid IP strategy that combines trade secret safeguards during manufacturing with trademark registration for brand identity.

How does SREKE protect my intellectual property?

We protect IP through legally binding NDAs, segregated production workflows, restricted data access, and secure document management. Our team signs individual confidentiality agreements, and all formulation data is stored on encrypted servers with audit trails. We do not share your formulation details with other clients under any circumstances.

What is the typical lead time for OEM supplement production?

Standard lead times at SREKE range from 30 to 60 days for most product forms, depending on formulation complexity, packaging requirements, and regulatory documentation. Custom packaging and NDI filing support may extend timelines. We provide detailed production schedules during the quoting phase.

Do you support international market compliance?

Yes. Our compliance team has experience with FDA (U.S.), EFSA (EU), Health Canada, TGA (Australia), and ASEAN regulatory frameworks. We can tailor formulations, labeling, and documentation to meet the specific requirements of your target markets.

What GMP certifications does SREKE hold?

SREKE operates under GMP certification verified by third-party auditors, ISO 22000 food safety management certification, and HACCP protocols. Our facility undergoes regular audits to maintain compliance with international quality standards.

Ready to launch your supplement brand? SREKE provides GMP-certified OEM/ODM manufacturing for softgels, capsules, tablets, powders, gummies, and liquids. Contact us for a free quote or email [email protected] — we respond within 24 hours.